5 May 2023
SHARE NOW
ATW
Cell Therapy
Finance & Investment
Gene Therapy
Scaling Up
Strategy
This Briefing from Advanced Therapies Week 2023 focusses on the delivery of a fully funded, third party biotech facility over an expedited timeline compared to traditional build construction methods.
During this session, Tony Wells (CEO) and Matthew Toomey (Business Development Director) from Merit are joined by Piers Slater, CEO at Reef Group, Will Rohleder, Director at Reef Group, Miranda Neville, VP of Global Operations & Delivery at Autolus and Olivia Drew, Portfolio Manager at UBS UK Life Sciences.
This Briefing was presented at Advanced Therapies Week 2023, in partnership with Merit.
More like this
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a cost-effective, high-productivity extracellular vesicle (EV) production platform that overcomes traditional manufacturing challenges? Join us to discover how Univercells Technologies’ scalable fixed-bed design is transforming EV manufacturing.
14 May 2024
Women in Advanced Therapies Global 2024, Virtual Event
Experience Women in Advanced Therapies Global, a 24-hour online event uniting the community in celebration of inspiration, innovation, and empowerment. Access exclusive insights, workshops, and networking opportunities from anywhere.
8 April 2024
